in this issue
Regions :: Western Europe :: Germany
Evonik posts lower sales and earnings, readies IPO
March 18, 2013 | —Natasha Alperowicz
Evonik Industries reported a 6% drop in fourth-quarter Ebitda, to €492 million ($641.7 million), on 2% lower sales, to €3.27 billion, attributing the decline to destocking by customers and economic weakness. Net income was 86% higher, to €276 million, mainly because of tax effects....
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee